Hummer Financial Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,586
Closed -$213K 134
2026
Q1
$213K Buy
+7,586
New +$202K 0.15% 122
2025
Q1
Sell
-7,786
Closed -$207K 110
2024
Q4
$207K Hold
7,786
0.16% 108
2024
Q3
$225K Hold
7,786
0.18% 100
2024
Q2
$218K Sell
7,786
-100
-1% -$2.75K 0.19% 97
2024
Q1
$219K Buy
7,886
+500
+7% +$13.9K 0.18% 101
2023
Q4
$213K Sell
7,386
-300
-4% -$9.07K 0.19% 97
2023
Q3
$255K Hold
7,686
0.26% 79
2023
Q2
$282K Hold
7,686
0.28% 77
2023
Q1
$314K Buy
7,686
+60
+0.8% +$2.59K 0.33% 72
2022
Q4
$391K Hold
7,626
0.43% 61
2022
Q3
$334K Hold
7,626
0.39% 64
2022
Q2
$400K Sell
7,626
-150
-2% -$7.64K 0.45% 57
2022
Q1
$403K Buy
7,776
+600
+8% +$31.1K 0.36% 66
2021
Q4
$424K Sell
7,176
-1,200
-14% -$59.5K 0.36% 64
2021
Q3
$360K Hold
8,376
0.33% 69
2021
Q2
$328K Hold
8,376
0.3% 74
2021
Q1
$303K Sell
8,376
-100
-1% -$3.55K 0.29% 77
2020
Q4
$312K Sell
8,476
-1,327
-14% -$48.7K 0.33% 73
2020
Q3
$341K Hold
9,803
0.4% 60
2020
Q2
$304K Buy
9,803
+105
+1% +$3.57K 0.39% 59
2020
Q1
$300K Buy
9,698
+633
+7% +$21.6K 0.45% 57
2019
Q4
$337K Buy
+9,065
New +$323K 0.36% 72

Other funds holding PFE

Hummer Financial Advisory Services's PFE Position: Q2 2026 in Review

Hummer Financial Advisory Services sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,586 shares — an estimated $213K sold.

Hummer Financial Advisory Services first reported a position in PFE in Q4 2019 and held it in 22 quarters. The position peaked at $424K in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hummer Financial Advisory Services reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Hummer Financial Advisory Services sold 7,586 Pfizer shares in Q2 2026, an estimated $213K.
  • Hummer Financial Advisory Services first reported a position in Pfizer in Q4 2019 and held it in 22 quarters.
  • Hummer Financial Advisory Services's Pfizer position peaked at $424K in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hummer Financial Advisory Services's 13F filing for Q2 2026, filed 7 Jul 2026.